Azithromycin Protects Against SO2 Induced Lung Injury
REYKJAVIK, ICELAND – 21 September 2020 – EpiEndo Pharmaceuticals (www.epiendo.com) is pleased to share important findings in a poster at...
OUR NEWS & EVENTS
- Jan 16, 2020
EpiEndo Attends the 6th Annual LSX World Congress 2020
For 6 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life sciences.
- Dec 18, 2019
EpiEndo Set to Receive a Grant From the European Innovation Council
EpiEndo is very proud to be among 75 promising start-ups and SMEs to be selected by the European Innovation Council (EIC) to receive a grant
- Sep 11, 2019
EpiEndo attends RESI Boston 2019
EpiEndo’s Founder, Fridrik Runar Gardarsson and Finnur Fridrik Einarsson (COO) will represent EpiEndo at the RESI conference in Boston on...
- Sep 10, 2019
EpiEndo Raises Eur 2 Million in Equity
EpiEndo successfully closed our 4th seed round of 2 million Euros.
- Sep 5, 2019
Nordic Life Science Days 2019
EpiEndo’s CEO, Fredrik Lehmann will represent EpiEndo at Nordic Life Science Days in Malmö on the 10th to 12th of September. He will also...
- Sep 3, 2019
Jennifer Kricker Joins EpiEndo
EpiEndo welcomes Jennifer Kricker, PhD to the team. Jennifer will take the role of Project Director. Jennifer has been involved with...
- Sep 1, 2019
EpiEndo nominated for the Nordic Life Science Awards 2019
EpiEndo has been nominated for the Nordic Life Science Business Class and Deligates choice Awards EpiEndo is among 9 BioTechs that are...
- Apr 4, 2019
Professors Peter Barnes, Dave Singh and Carl Persson join EpiEndo's Scientific Advisory Board
EpiEndo is proud to introduce new external advisers to our Scientific Advisory Board (SAB) and welcome Professors Peter Barnes, Dave...
- Jan 17, 2019
EpiEndo Pharmaceuticals Raises €800,000 to Advance Breakthrough Treatments for Respiratory Diseases
EpiEndo is pleased to announce that we have successfully closed a financing round of ISK 110 million (800.000 EUR). The financing was led...
- Sep 1, 2018
Fredrik Lehmann appointed CEO of EpiEndo
EpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo. Fredrik has a PhD in Medicinal Chemistry from the...
- Jun 29, 2018
Grant from the Icelandic Technology Development Fund
EpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo. EpiEndo Pharmaceuticals has signed a grant agreement...
- Mar 18, 2017
New board members join EpiEndo Pharmaceuticals
The following were appointed to the board of EpiEndo Pharmaceuticals at the Annual General Meeting on 17 March 2017. Professor Clive Page...
- Jan 31, 2017
EpiEndo Pharmaceuticals is granted EU Horizon 2020 award
EpiEndo Pharmaceuticals are proud to announce that we have been granted a Horizon 2020 grant from the European Union (EU) for the...
- May 25, 2016
EpiEndo Pharmaceuticals receives RANNIS Technology Development Fund award
EpiEndo Pharmaceuticals is proud to announce that we have received a 3 year grant from the Technology Development Fund, which is managed...
- Oct 11, 2014
EpiEndo Pharmaceuticals announces new partnership with Recipharm
EpiEndo Pharmaceuticals are proud to announce our new partnership with Recipharm, a Swedish Contract Development and Manufacturing...
- Jun 2, 2014
EpiEndo Pharmaceuticals awarded RANNIS Innovator Grant
EpiEndo Pharmaceuticals has been granted a 2 year grant by RANNÍS - The Icelandic Centre for Research - for compound research and patent...